• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

Should Birth at 37 Weeks be Considered an Intermediate Risk Group for Adverse Perinatal Outcomes and Mortality?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Early-term period (37 weeks–38 weeks) associated with higher risks than term (39–41 weeks)
  • Studies often combine births at 37 and 38 weeks
  • Eskes et al. (BJOG, 2019) assessed neonatal mortality and morbidity risk by separating out 37 weeks specifically

METHODS:

  • Nationwide cohort study
    • Data from the national perinatal registry (PERINED) that covers 99% of deliveries in the Netherlands
  • Participants
    • Singleton delivery at term (37w0d – 41w6d) | No congenital malformations | 5-year period (2010-2015)
  • Primary outcomes
    • Mortality (definition): Intrapartum or neonatal mortality during the first 4 weeks of life
    • Adverse neonatal outcome (definition): ≥1 of the following
      • Neonatal mortality
      • Low 5-minute Apgar score (<7)
      • NICU admission
  • Data and analysis
    • 37 week group compared to 39-41 week group
    • Odds ratio (OR) adjusted for: Parity | Age | Ethnicity | Socio-economic status | Hypertensive disordere | SGA (<10th BW centile)
    • Logistic regression to assess indication and mode of delivery

RESULTS:

  • 755,198 women were included
  • Neonatal mortality was higher at 37 weeks (1.10%) vs 39-41 weeks (0.59%) (P < 0.0001)
    • Adjusted OR 1.84 (95% CI 1.39–2.44)
  • Adverse neonatal outcomes were more likely at 37 weeks (21.4%) vs 39-41 weeks (12.04%) (P < 0.0001)
    • aOR 1.63 (95% CI 1.53–1.74)
  • Spontaneous start of labor at 37 weeks was associated with increased neonatal mortality
    • aOR 2.20 (95% CI 1.56–3.10)
    • Risk not influenced by primary (midwifery) vs specialist care
    • Risk was specific to spontaneous start of labor and not influenced by induction or planned cesarean

CONCLUSION:

  • Birth at 37 weeks are independently associated with a higher frequency of adverse perinatal outcomes than birth at 39-41 weeks
  • The authors recommend for intensive monitoring during labor for this group and state

Our findings provide a reason to regard the start of labour at 37 weeks of gestation not as low risk but as an intermediate group between preterm and term birth with clearly elevated perinatal risk.

Learn More – Primary Sources:

The risk of intrapartum/neonatal mortality and morbidity following birth at 37 weeks of gestation: a nationwide cohort study

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

Learn More  »

image_pdfFavoriteLoadingFavorite
< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Does Extending Pregnancy Beyond 39 weeks in Low-risk Pregnancies Incur Additional Risk?
Is the Change in Gestational Age Distribution in the US Having an Effect on Perinatal Mortality?
Delivery at 37 or 39 Weeks for Higher Order Cesarean Sections?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site